Analysts Anticipate 11% Upside For IVW

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares S&P 500 Growth ETF (Symbol: IVW), we found that the implied analyst target price for the ETF based upon its underlying holdings is $74.36 per unit.

With IVW trading at a recent price near $67.19 per unit, that means that analysts see 10.67% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IVW's underlying holdings with notable upside to their analyst target prices are Bristol Myers Squibb Co. (Symbol: BMY), Chevron Corporation (Symbol: CVX), and Campbell Soup Co (Symbol: CPB). Although BMY has traded at a recent price of $65.16/share, the average analyst target is 20.53% higher at $78.54/share. Similarly, CVX has 19.24% upside from the recent share price of $159.83 if the average analyst target price of $190.58/share is reached, and analysts on average are expecting CPB to reach a target price of $53.40/share, which is 15.89% above the recent price of $46.08. Below is a twelve month price history chart comparing the stock performance of BMY, CVX, and CPB: